Public Reporting & Performance

ACO Name & Location

Baroma Accountable Care, LLC
d/b/a BAROMA Health Partners

10900 NW 25th Street
Suite 200
Miami, FL 33172

ACO Primary Contact

Rene Valverde/President,
(305) 748-6147
rvalverde@baromahc.com

ACO Governing Body

Baroma Accountable Care Member Title/ Position ACO Participant TIN Legal Business Name
Eduardo Alarcon MD/Chair N/A
Gilda M De la Calle MD/Member Gilda De La Calle MD PA
Jorge Perez MD/Member N/A
Jose Manuel Armas MD/Member N/A
Javier Perez MD/Member Javier Perez MD PA
Virgilio Sanchez MD/Member N/A
Rheinchard Reyes MD/Co-Chair Rheinchard Reyes MD PA
Gladys Alonso MD/Member Gladys Y. Alonso MD PA
Carlos Iglesias MD/Member Carlos Iglesias MD PA
Marcelo Bendix MD/Member N/A
Jose Armas MD/Member N/A
Jose Deus-Fernandez MD/Member N/A
Vladimir Diaz MD/Member N/A
Vacant Medicare Beneficiary N/A
Cathy F. Bowers Consumer Advocate N/A
Jeffrey Lawrence CFO N/A

Baroma Accountable Care, LLC Key Administrative and Clinical Leadership Personnel

Rene J Valverde President at Baroma ACO
Janette Rojas Compliance Officer at Baroma ACO
Dr. Eduardo Alarcon Chairman/Medical Director at Baroma ACO
Kirenia Mijares Clinical Improvement Officer at Baroma ACO
Dr. Maria Labarga Chief Medical Officer

ACO Key Committees

Committee Chair Co-Chair
Clinical/Quality Eduardo Alarcon; N/A Rheinchard Reyes MD; Rheinchard Reyes MD PA
Beneficiary
Outreach/Engagement
Marcelo Bendix; N/A Javier Perez MD; Javier Perez MD PA
Provider
Finance/Advisory
Vladimir Diaz; N/A. Jorge Perez; N/A

Amount of Shared Savings/Losses

Performance Year 1: TBD
Performance Year 2: TBD
Performance Tear 3: TBD

How Shared Savings Are Distributed

Reinvest in infrastructure: Minimum of 5%
2016 Distribution to ACO Participants: 75% of shared savings net of ACO’s operating costs

Quality Performance Results

As a Next Generation ACO, Baroma ACO posts quality performance results each year. The next results will be posted in 2017

NGACO Participation Waivers

On December 9, 2015, the Secretary of the Department of Health & Human Services issued waivers of certain federal fraud and abuse laws in its Notice of Waiver of Certain Fraud and Abuse Laws in Connection with the Next Generation ACO Model, including the Next Generation ACO Participation Waiver. This disclosure is intended to qualify the investment by HCA, Inc. and its affiliates, through hInsight-BMA Holdings, LLC, into the parent company of Baroma Accountable Care, LLC (the “Investment”) for waiver protection under the Next Generation ACO Participation Waiver. The governing bodies of Baroma Accountable Care, LLC and its parent have duly authorized and made a bona fide determination that the Investment will assist in the development of the infrastructure of the Baroma Accountable Care, LLC ACO and further the coordination of care to Medicare beneficiaries and that such investment is reasonably related to the purposes and goals of the Next Generation ACO Model.

This disclosure is intended to provide public notice of the following arrangement with Quest Diagnostics as required under the Next Generation ACO Participation Waiver. The governing bodies of Baroma Accountable Care, LLC ACO have duly authorized and made a bona determination to collaborate with Quest Diagnostics, to provide enhanced laboratory services to Medicare Beneficiaries, and to further create an opportunity to improve healthcare and cost outcomes. Quest Diagnostics will assist in the development of the infrastructure of the ACO and further the coordination of care to Medicare beneficiaries and that such investment is reasonable related to the purposes and goals of the Next Generation ACO Model.

ACO Joint Ventures

The ACO has no joint ventures between or among the ACO and any of its Participants and Preferred Providers.